Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Gen Virol ; 93(Pt 7): 1495-1505, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22492917

ABSTRACT

The recently described anti-human immunodeficiency virus type 1 (HIV-1) human mAb PG9 and PG16 are cross-clade broadly neutralizing. Therefore, it can be postulated that the targeted epitope(s) are highly conserved among variants of the entire group M. We analysed the sensitivity to PG9 and PG16 of pseudotyped viruses carrying envelope glycoproteins from the viral quasispecies of three HIV-1 clade CRF01_AE-infected patients. The broad heterogeneity in sensitivity to PG9 and PG16, despite closely genetically related envelope glycoproteins issued from single individuals, allowed us to identify two gp120 cross-clade conserved residues, a lysine at position 168 in the V2 loop and an isoleucine at position 215 in the C2 region, whose substitutions were associated with resistance to PG9 and PG16. By site-directed mutagenesis, we confirmed both in clades B and CRF01_AE that the substitutions K168E and I215M have a major impact on PG9 and PG16 neutralization sensitivity of pseudotyped viruses.


Subject(s)
Antibodies, Neutralizing/immunology , HIV Antibodies/immunology , HIV Infections/virology , HIV-1/immunology , Mutation, Missense , env Gene Products, Human Immunodeficiency Virus/genetics , env Gene Products, Human Immunodeficiency Virus/immunology , Amino Acid Substitution , Antibodies, Monoclonal/immunology , DNA Mutational Analysis , HIV-1/genetics , HIV-1/isolation & purification , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , Mutant Proteins/genetics , Mutant Proteins/immunology , Neutralization Tests , RNA, Viral/genetics , Sequence Analysis, DNA
2.
Virology ; 426(1): 12-21, 2012 Apr 25.
Article in English | MEDLINE | ID: mdl-22310702

ABSTRACT

Several studies have shown that the early virus population present in HIV-1 infected infants usually is homogeneous when compared to the highly diversified viral population present at delivery in their mothers. We explored the antigenic and functional properties of pseudotyped viruses expressing gp120 encoded by env clones issued from four mother-infant pairs infected by CRF01_AE viruses. We compared their sensitivity to neutralization and to entry inhibitors, their infectivity levels and the Env processing and incorporation levels. We found that both transmitted viruses present in infants and the variants present in their chronically infected mothers display a wide spectrum of biological properties that could not distinguish between them. In contrast, we found that all the transmitted viruses in the infants were more sensitive to neutralization by PG9 and PG16 than the maternal variants, an observation that may have implications for the development of prophylactic strategies to prevent mother-to-child transmission.


Subject(s)
HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/immunology , HIV Infections/virology , HIV-1/immunology , Infectious Disease Transmission, Vertical , Adult , Cell Line , Female , Genetic Variation , HIV Antibodies/immunology , HIV Infections/immunology , HIV Infections/transmission , HIV-1/classification , HIV-1/genetics , HIV-1/isolation & purification , Humans , Infant , Male , Molecular Sequence Data , Neutralization Tests , Phylogeny
3.
J Virol ; 85(7): 3642-8, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21248038

ABSTRACT

The broadly neutralizing human monoclonal antibody 2G12 binds to a carbohydrate-dependent epitope involving three major potential N-linked glycosylation sites (PNGS) of gp120 (N295, N332, and N392). Through analysis of the sensitivity to 2G12 of pseudotyped viruses carrying envelope proteins from HIV-1 clade B-infected long-term nonprogressors, we selected two naturally occurring env clones with opposite sensitivities to 2G12, albeit harboring the 3 particular PNGS known to be essential for 2G12 binding (N295, N332, and N392). The resistant clone presented a long and potentially heavily glycosylated V1V2 loop and an additional PNGS (N302) in the V3 loop. The sensitive clone harbored a short V1V2 loop and lacked the PNGS at N302. We created chimeric envelope genes by swapping the V1V2 domains of the two env clones. The influence of N302 on 2G12 sensitivity was assessed by PCR-based site-directed mutagenesis. Both the exchange of the V1V2 domain and the introduction of the PNGS at N302 on the 2G12-sensitive clone induced a significant decrease in sensitivity to 2G12. In contrast, the reverse V1V2 exchange and the removal of the PNGS at N302 on the 2G12-resistant clone increased sensitivity to 2G12, confirming the influence of these regions on 2G12 sensitivity. Our results, supported by a molecular-modeling study, suggest that both the V1V2 loop and an additional PNGS in V3 might limit access to the 2G12 epitope.


Subject(s)
Antibodies, Neutralizing/immunology , HIV Antibodies/immunology , HIV Envelope Protein gp120/immunology , HIV-1/immunology , HIV Envelope Protein gp120/genetics , HIV-1/genetics , Humans , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Mutant Proteins/genetics , Mutant Proteins/immunology , Neutralization Tests , Recombination, Genetic , Sequence Analysis, DNA
4.
Virology ; 387(2): 388-94, 2009 May 10.
Article in English | MEDLINE | ID: mdl-19303619

ABSTRACT

Mother-to-child transmission (MTCT) of HIV-1 provides a model for studying the role of passively acquired antibodies in preventing HIV infection. We determined the titers of neutralizing antibodies (NAbs) against six primary isolates of clades B and CRF01_AE in sera from 45 transmitting and 45 nontransmitting mothers matched for the main independent factors associated with MTCT in Thailand. A lower risk of MTCT, particularly for intrapartum transmission, was associated only with higher NAb titers against the CRF01_AE strain, MBA. The envelope glycoprotein of this strain showed an unusually long V2 domain of 63 amino acids, encoding six potential N-linked glycosylation sites. We provided experimental data indicating that the extended V2 domain contributed to the higher level of resistance to neutralization by mothers' sera in this strain. Taken together the data suggest that some primary isolates with specific properties may be useful indicators for identifying protective antibodies.


Subject(s)
HIV Antibodies/blood , HIV Infections/blood , HIV Infections/transmission , HIV-1/immunology , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/blood , Adult , Amino Acid Sequence , Antibody Specificity , Female , HIV Antibodies/immunology , HIV Envelope Protein gp120/chemistry , HIV Envelope Protein gp120/immunology , Humans , Molecular Sequence Data , Neutralization Tests , Pregnancy , Pregnancy Complications, Infectious/virology , Protein Structure, Tertiary/genetics , Sequence Alignment , Thailand
SELECTION OF CITATIONS
SEARCH DETAIL
...